Trial intelligence / Profile preview

Silodosin for Ureteral Dilatation in Flexible Ureterorenoscopy

NCT05798572Completed

Sponsor
Benha University
Start
Mar 2022
Primary completion
Mar 2023
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in urolithiasis comparing Silodosin group with Placebo group (2 arms). Primary endpoint: Entrance to bladder time. Started Mar 2022; status: completed.

02

Drugs

silodosin
03

Conditions

urolithiasis

Beyond the preview

Go deeper on NCT05798572.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05798572.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call